ScholarWorks@Hanyang University ERICA Campus: Son, Kyung-Bok

Detailed Information

Son, Kyung-Bok (손경복)

COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)

Research Area: 보건(의약품)경제학, 보건(의약품)정책, 의약품 정치경제, Health(Pharmaceutical) Economics, Health(Pharmaceutical) Policy, Political Economics of Pharmaceuticals

Tel 031-400-5812
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

South Korea:26||Access to medicines:4||access to medicines:3||Compulsory licensing:3||COVID19:3||market exclusivity:3||Pharmaceutical expenditure:2||New drug:2||Cost:2||generic drugs:2||Burden of disease:2||Generic competition:2||Free trade agreements:2||pharmaceutical:2||community pharmacy:2||competition:2||pharmaceutical expenditure:2||HIV/AIDS:2||Patent linkage:2||pharmaceuticals:2||Constructive ambiguity:2||Incidence:2||Market:1||Market competition:1||Market share:1||NOAC:1||New medicine:1||Noncervical anogenital cancer:1||Nonvalvular atrial fibrillation:1||Offpatent original drug:1||Oropharyngeal cancer:1||Patent challenge:1||Patent challenges:1||Patent system:1||Patenting:1||Pharmaceutical policy:1||Pharmacists’ income:1||Pharmacy education:1||Pharmacy school:1||Prescribing:1||Price variance:1||Pricing and reimbursement:1||Pricing schemes:1||Primary care:1||Primary care business:1||Procedural fairness:1||Prospecting:1||Reimbursement coverage:1||Reimbursement decision:1||Reimbursement decisions:1||Risk sharing arrangement:1||Sales growth:1||South Korean pharmaceutical industry:1||South korea:1||Statins:1||TRIPSplus:1||Therapeutic market size:1||Uncertainty:1||Value judgments:1||VitaminK antagonist:1||a retrospective study:1||a usual source of care:1||access to medicine:1||cohort study:1||compulsory licensing:1||compulsory licensing duration:1||costsharing schemes:1||development scale:1||dose adjustment:1||drug choice:1||drug entry:1||drug lag:1||equity in utilization:1||event history model:1||evidenceinformed deliberative process:1||eye drop:1||first generic exclusivity:1||first mover:1||followon drugs:1||free trade agreement:1||free trade agreements:1||generic entrants:1||globalisation:1||half tablet:1||health financing:1||health system:1||health technology assessment:1||highcost medicines:1||hotlines:1||incentive for early generic entry:1||intellectual property:1||international agreements:1||latecomers:1||linkage:1||lowpriced generics:1||market competition:1||market structure:1||marketing and pricing strategies:1||medicine:1||medicinecentered services:1||medicines:1||medicines regulatory agency:1||multilevel modeling:1||offpatent drugs:1||pandemic:1||patent challenge:1||patent challenges:1||patent linkage:1||patent linkage system:1||patentlinkage system:1||patient response:1||pharmaceutical care:1||pharmaceutical drug branding:1||pharmaceutical market:1||pharmaceutical practice:1||pharmacists:1||pharmacy:1||physician response:1||prescription drugs:1||primary care:1||public perception:1||realist review:1||reimbursement:1||reimbursement decisions:1||reputation:1||risk sharing agreements:1||social distancing:1||statin utilization:1||statins:1||survey:1||tablet splitting:1||tablet subdivision:1||the first generic:1||trends in eye drop utilization:1||uncertainty:1||universal health coverage:1||validation:1||violence:1||Access to new drugs:1||Adoption of new drugs:1||Anatomical therapeutic chemical classification:1||Anticoagulant:1||Carcinoma in situ:1||Cervical cancer:1||Competition:1||Costeffectiveness:1||Delay in access:1||Drug price:1||Drug reimbursement:1||Economic evaluation:1||Event history model:1||Free Trade Agreements:1||Generics:1||HPV:1||Intellectual property:1||International agreements:1||KORUS FTA:1||Key words Health technology assessment:1||Linkage:1||

RSS_1.0 RSS_2.0 ATOM_1.0

55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE